Lista de obras - Nicoletta Fortunati - Dominio Público Uruguay

Altered expression of androgen-receptor isoforms in human colon-cancer tissues.

artículo científico publicado en 2000

Binding of sex steroid binding protein to plasma membranes of human testis

artículo científico publicado en 1994

Biological relevance of the interaction between sex steroid binding protein and its specific receptor of MCF-7 cells: Effect on the estradiol-induced cell proliferation

artículo científico publicado en 1993

Control of the membrane sex hormone-binding globulin-receptor (SHBG-R) in MCF-7 cells: effect of locally produced SHBG.

artículo científico publicado en 1998

Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo

artículo científico publicado en 2011

Doxorubicin-Loaded Nanobubbles Combined with Extracorporeal Shock Waves: Basis for a New Drug Delivery Tool in Anaplastic Thyroid Cancer.

artículo científico publicado en 2016

Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.

artículo científico publicado en 2011

Emerging molecular therapies of advanced thyroid cancer.

artículo científico publicado en 2010

Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG)

artículo científico publicado en 1999

Estrogen receptor alpha is a novel marker expressed by follicular dendritic cells in lymph nodes and tumor-associated lymphoid infiltrates

artículo científico publicado en 2003

Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.

artículo científico publicado en 2006

Extracorporeal shock waves modulate myofibroblast differentiation of adipose-derived stem cells.

artículo científico publicado en 2016

GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution

artículo científico publicado en 2014

High Energy Shock Waves (HESW) Enhance Paclitaxel Cytotoxicity in MCF-7 Cells ⬇️

artículo científico publicado el 1 de septiembre de 2003

High energy shock waves activate 5'-aminolevulinic Acid and increase permeability to Paclitaxel: antitumor effects of a new combined treatment on anaplastic thyroid cancer cells.

artículo científico publicado en 2007

Histone Deacetylase Inhibition Modulates E-Cadherin Expression and Suppresses Migration and Invasion of Anaplastic Thyroid Cancer Cells

artículo científico publicado en 2012

Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.

artículo científico publicado en 2013

Hormonal and clinic evaluation of patients with moderate body hair growth

artículo científico publicado en 1993

MCF-7 cell progesterone receptor (PGR) is additionally modulated by sex steroid binding protein (SBP) and its membrane receptor (SBP-R) through cAMP and PKA.

artículo científico publicado en 1996

Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience

artículo científico publicado en 2015

Modulation by cytokines of glucocorticoid action.

artículo científico publicado en 1999

Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure.

artículo científico publicado en 2008

O-Glycosylation of human sex hormone-binding globulin is essential for inhibition of estradiol-induced MCF-7 breast cancer cell proliferation.

artículo científico publicado en 2002

Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach

artículo científico publicado en 2020

Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cellsvia cyclic adenosine monophosphate and protein kinase A

artículo científico publicado en 1997

Pituitary lesions in breast cancer patients: A report of three cases.

artículo científico publicado en 2015

Plasma Sex Steroid Transport and Histamine H2-Receptor Antagonists

artículo científico publicado en 1988

Receptor for sex steroid-binding protein of endometrium membranes: solubilization, partial characterization, and role of estradiol in steroid-binding protein-soluble receptor interaction

artículo científico publicado en 1992

Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer

scientific article published on 19 September 2009

Sex steroid binding protein (SBP) receptors in estrogen sensitive tissues.

artículo científico publicado en 1991

Sex steroid binding protein is a negative modulator of estrogen-induced breast cancer cell growth.

artículo científico publicado en 1996

Sex steroid binding protein receptor (SBP-R) is related to a reduced proliferation rate in human breast cancer

artículo científico publicado en 1997

Sex steroid-binding protein interacts with a specific receptor on human premenopausal endometrium membrane: modulating effect of estradiol☆

artículo científico publicado en 1991

Smoking Effects on the Hormonal Balance of Fertile Women

artículo científico publicado en 1992

Somatic alterations of the androgen receptor CAG repeat in human colon cancer delineate a novel mutation pathway independent of microsatellite instability

artículo científico publicado en 2000

The additionally glycosylated variant of human sex hormone‐binding globulin (SHBG) is linked to estrogen‐dependence of breast cancer

scientific article published on 01 March 1999

The androgen receptor CAG repeat: a modifier of carcinogenesis?

artículo científico publicado en 2002

The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotype.

artículo científico publicado en 2013

The receptor for human sex steroid binding protein (SBP) is expressed on membranes of neoplastic endometrium

artículo científico publicado en 1992

The receptor-mediated action of sex steroid binding protein (SBP, SHBG): accumulation of cAMP in MCF-7 cells under SBP and estradiol treatment.

artículo científico publicado en 1994

Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines.

artículo científico publicado en 2007

Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells

artículo científico publicado en 2004

Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells

artículo científico publicado en 2004

Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells

artículo científico publicado en 2007

Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells.

artículo científico publicado en 2009

Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells.

artículo científico publicado en 2006

Lista de obras de Nicoletta Fortunati

Altered expression of androgen-receptor isoforms in human colon-cancer tissues.

Binding of sex steroid binding protein to plasma membranes of human testis

Biological relevance of the interaction between sex steroid binding protein and its specific receptor of MCF-7 cells: Effect on the estradiol-induced cell proliferation

Control of the membrane sex hormone-binding globulin-receptor (SHBG-R) in MCF-7 cells: effect of locally produced SHBG.

Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo

Doxorubicin-Loaded Nanobubbles Combined with Extracorporeal Shock Waves: Basis for a New Drug Delivery Tool in Anaplastic Thyroid Cancer.

Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.

Emerging molecular therapies of advanced thyroid cancer.

Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG)

Estrogen receptor alpha is a novel marker expressed by follicular dendritic cells in lymph nodes and tumor-associated lymphoid infiltrates

Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.

Extracorporeal shock waves modulate myofibroblast differentiation of adipose-derived stem cells.

GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution

High Energy Shock Waves (HESW) Enhance Paclitaxel Cytotoxicity in MCF-7 Cells ⬇️

High energy shock waves activate 5'-aminolevulinic Acid and increase permeability to Paclitaxel: antitumor effects of a new combined treatment on anaplastic thyroid cancer cells.

Histone Deacetylase Inhibition Modulates E-Cadherin Expression and Suppresses Migration and Invasion of Anaplastic Thyroid Cancer Cells

Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.

Hormonal and clinic evaluation of patients with moderate body hair growth

MCF-7 cell progesterone receptor (PGR) is additionally modulated by sex steroid binding protein (SBP) and its membrane receptor (SBP-R) through cAMP and PKA.

Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience

Modulation by cytokines of glucocorticoid action.

Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure.

O-Glycosylation of human sex hormone-binding globulin is essential for inhibition of estradiol-induced MCF-7 breast cancer cell proliferation.

Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach

Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cellsvia cyclic adenosine monophosphate and protein kinase A

Pituitary lesions in breast cancer patients: A report of three cases.

Plasma Sex Steroid Transport and Histamine H2-Receptor Antagonists

Receptor for sex steroid-binding protein of endometrium membranes: solubilization, partial characterization, and role of estradiol in steroid-binding protein-soluble receptor interaction

Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer

Sex steroid binding protein (SBP) receptors in estrogen sensitive tissues.

Sex steroid binding protein is a negative modulator of estrogen-induced breast cancer cell growth.

Sex steroid binding protein receptor (SBP-R) is related to a reduced proliferation rate in human breast cancer

Sex steroid-binding protein interacts with a specific receptor on human premenopausal endometrium membrane: modulating effect of estradiol☆

Smoking Effects on the Hormonal Balance of Fertile Women

Somatic alterations of the androgen receptor CAG repeat in human colon cancer delineate a novel mutation pathway independent of microsatellite instability

The additionally glycosylated variant of human sex hormone‐binding globulin (SHBG) is linked to estrogen‐dependence of breast cancer

The androgen receptor CAG repeat: a modifier of carcinogenesis?

The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotype.

The receptor for human sex steroid binding protein (SBP) is expressed on membranes of neoplastic endometrium

The receptor-mediated action of sex steroid binding protein (SBP, SHBG): accumulation of cAMP in MCF-7 cells under SBP and estradiol treatment.

Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines.

Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells

Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells

Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells

Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells.

Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells.